Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06052111Completed
Randomised trial of dexmedetomidine in class III obesity (2 arms), sponsored by Helwan University. Primary endpoint: Time to extubation. Started May 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06052111.